Group One Trading’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-66
Closed -$1K 5950
2018
Q3
$1K Buy
+66
New +$660 ﹤0.01% 5117
2017
Q1
Sell
-23,189
Closed -$114K 5437
2016
Q4
$114K Buy
23,189
+10,926
+89% +$56K ﹤0.01% 2774
2016
Q3
$61K Sell
12,263
-3,063
-20% -$15.7K ﹤0.01% 3239
2016
Q2
$78K Sell
15,326
-46,805
-75% -$252K ﹤0.01% 3031
2016
Q1
$355K Sell
62,131
-65,132
-51% -$455K 0.01% 1948
2015
Q4
$1.32M Buy
127,263
+116,151
+1,045% +$1.58M 0.02% 1123
2015
Q3
$205K Sell
11,112
-33,406
-75% -$645K ﹤0.01% 2484
2015
Q2
$866K Buy
44,518
+14,513
+48% +$257K 0.01% 1328
2015
Q1
$527K Sell
30,005
-3,508
-10% -$58.9K 0.01% 1552
2014
Q4
$536K Sell
33,513
-73,992
-69% -$991K 0.01% 1494
2014
Q3
$1.35M Buy
107,505
+38,826
+57% +$554K 0.02% 913
2014
Q2
$1.07M Sell
68,679
-17,795
-21% -$262K 0.02% 1090
2014
Q1
$1.14M Buy
86,474
+80,341
+1,310% +$1.26M 0.02% 994
2013
Q4
$99K Buy
6,133
+6,007
+4,767% +$95.7K ﹤0.01% 3050
2013
Q3
$2K Sell
126
-12,358
-99% -$183K ﹤0.01% 5006
2013
Q2
$126K Buy
+12,484
New +$131K ﹤0.01% 2602

Other funds holding OSIR

Group One Trading's OSIR Position: Q4 2018 in Review

Group One Trading sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q4 2018, closing a stake of 66 shares — an estimated $1K sold.

Group One Trading first reported a position in OSIR in Q2 2013 and held it in 16 quarters. The position peaked at $1.35M in Q3 2014. 46 funds tracked by Wall St. Rank hold OSIR as of Q4 2018.

  • Group One Trading reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • Group One Trading sold 66 Osiris Therapeutics, Inc. Common Stock shares in Q4 2018, an estimated $1K.
  • Group One Trading first reported a position in Osiris Therapeutics, Inc. Common Stock in Q2 2013 and held it in 16 quarters.
  • Group One Trading's Osiris Therapeutics, Inc. Common Stock position peaked at $1.35M in Q3 2014.
  • 46 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q4 2018.

Based on Group One Trading's 13F filing for Q4 2018, filed 6 Feb 2019.